SLC16A1 and Alzheimer disease: The results showed a higher level of mRNA of monocarboxylate transporter 1 (MCT1) in AD/LS180, and Na/H+exchanger 1 (NHE1) in CAAs compared to control cells (this was observed as a tendency for AD/LoVo) (Fig. 2D).